Catalyst Wire Dossier Catalyst Wire Dossier

Etravirine (Intelence)

etravirine · Janssen
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Etravirine (Intelence), covering 2011-01-05 to 2021-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL [Phase 2]

See pricing